We're looking forward to attending the 15th annual scientific meeting of the International Society for CNS Clinical Trials and Methodology. Will we see you out in Washington, DC?
This year, our Director of Neuroscience, Dr Kiri Granger, will be chairing a working group on the subject of cognitive trajectories in schizophrenia.
The objective of the working group will be to review the available data pertaining to cognitive trajectories in recent clinical trials to ascertain the potential need to modify the recommendations for inclusion / exclusion criteria (i.e. patient selection) for clinical trials in CIAS.
Please click here for the latest available information on this working group. If you are interested in learning more about this subject, please email us.